"Global Subcutaneous Drug Delivery Market Overview:
Global Subcutaneous Drug Delivery Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Subcutaneous Drug Delivery Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Subcutaneous Drug Delivery involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Subcutaneous Drug Delivery Market:
The Subcutaneous Drug Delivery Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Subcutaneous Drug Delivery Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Subcutaneous Drug Delivery Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Subcutaneous Drug Delivery market has been segmented into:
Disposable
and Reusable
By Application, Subcutaneous Drug Delivery market has been segmented into:
Auto-immune Disorders
Neurological Disorders
Oncology Disorders
Hormonal Disorders
Allergy & Infectious Disorders
Ophthalmic Disorders
and Others
By Delivery System(Prefilled Syringes
Autoinjector
Pen Injectors
Disposable
and others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Subcutaneous Drug Delivery market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Subcutaneous Drug Delivery market.
Top Key Players Covered in Subcutaneous Drug Delivery market are:
Becton Dickinson and Company.
Novo Nordisk A/S
Johnson & Johnson
Novartis International AG
Amgen Inc.
Teva Pharmaceutical Industries Ltd
F. Hoffmann-La Roche AG.
Consort Medical plc LaVision Biotec GmbH
Eli Lilly and Company.
Merck & Co.
Inc
Insulet Corporation.
West Pharmaceutical Services
Inc. Gerresheimer AG.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Subcutaneous Drug Delivery Market by Type
4.1 Subcutaneous Drug Delivery Market Snapshot and Growth Engine
4.2 Subcutaneous Drug Delivery Market Overview
4.3 Disposable
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Disposable: Geographic Segmentation Analysis
4.4 and Reusable
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 and Reusable: Geographic Segmentation Analysis
Chapter 5: Subcutaneous Drug Delivery Market by Application
5.1 Subcutaneous Drug Delivery Market Snapshot and Growth Engine
5.2 Subcutaneous Drug Delivery Market Overview
5.3 Auto-immune Disorders
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Auto-immune Disorders: Geographic Segmentation Analysis
5.4 Neurological Disorders
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Neurological Disorders: Geographic Segmentation Analysis
5.5 Oncology Disorders
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Oncology Disorders: Geographic Segmentation Analysis
5.6 Hormonal Disorders
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Hormonal Disorders: Geographic Segmentation Analysis
5.7 Allergy & Infectious Disorders
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Allergy & Infectious Disorders: Geographic Segmentation Analysis
5.8 Ophthalmic Disorders
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Ophthalmic Disorders: Geographic Segmentation Analysis
5.9 and Others
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 and Others: Geographic Segmentation Analysis
5.10 By Delivery System(Prefilled Syringes
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 By Delivery System(Prefilled Syringes: Geographic Segmentation Analysis
5.11 Autoinjector
5.11.1 Introduction and Market Overview
5.11.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.11.3 Key Market Trends, Growth Factors and Opportunities
5.11.4 Autoinjector: Geographic Segmentation Analysis
5.12 Pen Injectors
5.12.1 Introduction and Market Overview
5.12.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.12.3 Key Market Trends, Growth Factors and Opportunities
5.12.4 Pen Injectors: Geographic Segmentation Analysis
5.13 Disposable
5.13.1 Introduction and Market Overview
5.13.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.13.3 Key Market Trends, Growth Factors and Opportunities
5.13.4 Disposable: Geographic Segmentation Analysis
5.14 and others
5.14.1 Introduction and Market Overview
5.14.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.14.3 Key Market Trends, Growth Factors and Opportunities
5.14.4 and others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Subcutaneous Drug Delivery Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BECTON DICKINSON AND COMPANY.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 NOVO NORDISK A/S
6.4 JOHNSON & JOHNSON
6.5 NOVARTIS INTERNATIONAL AG
6.6 AMGEN INC.
6.7 TEVA PHARMACEUTICAL INDUSTRIES LTD
6.8 F. HOFFMANN-LA ROCHE AG.
6.9 CONSORT MEDICAL PLC LAVISION BIOTEC GMBH
6.10 ELI LILLY AND COMPANY.
6.11 MERCK & CO.
6.12 INC
6.13 INSULET CORPORATION.
6.14 WEST PHARMACEUTICAL SERVICES
6.15 INC. GERRESHEIMER AG.
Chapter 7: Global Subcutaneous Drug Delivery Market By Region
7.1 Overview
7.2. North America Subcutaneous Drug Delivery Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Disposable
7.2.4.2 and Reusable
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Auto-immune Disorders
7.2.5.2 Neurological Disorders
7.2.5.3 Oncology Disorders
7.2.5.4 Hormonal Disorders
7.2.5.5 Allergy & Infectious Disorders
7.2.5.6 Ophthalmic Disorders
7.2.5.7 and Others
7.2.5.8 By Delivery System(Prefilled Syringes
7.2.5.9 Autoinjector
7.2.5.10 Pen Injectors
7.2.5.11 Disposable
7.2.5.12 and others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Subcutaneous Drug Delivery Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Disposable
7.3.4.2 and Reusable
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Auto-immune Disorders
7.3.5.2 Neurological Disorders
7.3.5.3 Oncology Disorders
7.3.5.4 Hormonal Disorders
7.3.5.5 Allergy & Infectious Disorders
7.3.5.6 Ophthalmic Disorders
7.3.5.7 and Others
7.3.5.8 By Delivery System(Prefilled Syringes
7.3.5.9 Autoinjector
7.3.5.10 Pen Injectors
7.3.5.11 Disposable
7.3.5.12 and others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Subcutaneous Drug Delivery Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Disposable
7.4.4.2 and Reusable
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Auto-immune Disorders
7.4.5.2 Neurological Disorders
7.4.5.3 Oncology Disorders
7.4.5.4 Hormonal Disorders
7.4.5.5 Allergy & Infectious Disorders
7.4.5.6 Ophthalmic Disorders
7.4.5.7 and Others
7.4.5.8 By Delivery System(Prefilled Syringes
7.4.5.9 Autoinjector
7.4.5.10 Pen Injectors
7.4.5.11 Disposable
7.4.5.12 and others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Subcutaneous Drug Delivery Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Disposable
7.5.4.2 and Reusable
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Auto-immune Disorders
7.5.5.2 Neurological Disorders
7.5.5.3 Oncology Disorders
7.5.5.4 Hormonal Disorders
7.5.5.5 Allergy & Infectious Disorders
7.5.5.6 Ophthalmic Disorders
7.5.5.7 and Others
7.5.5.8 By Delivery System(Prefilled Syringes
7.5.5.9 Autoinjector
7.5.5.10 Pen Injectors
7.5.5.11 Disposable
7.5.5.12 and others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Subcutaneous Drug Delivery Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Disposable
7.6.4.2 and Reusable
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Auto-immune Disorders
7.6.5.2 Neurological Disorders
7.6.5.3 Oncology Disorders
7.6.5.4 Hormonal Disorders
7.6.5.5 Allergy & Infectious Disorders
7.6.5.6 Ophthalmic Disorders
7.6.5.7 and Others
7.6.5.8 By Delivery System(Prefilled Syringes
7.6.5.9 Autoinjector
7.6.5.10 Pen Injectors
7.6.5.11 Disposable
7.6.5.12 and others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Subcutaneous Drug Delivery Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Disposable
7.7.4.2 and Reusable
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Auto-immune Disorders
7.7.5.2 Neurological Disorders
7.7.5.3 Oncology Disorders
7.7.5.4 Hormonal Disorders
7.7.5.5 Allergy & Infectious Disorders
7.7.5.6 Ophthalmic Disorders
7.7.5.7 and Others
7.7.5.8 By Delivery System(Prefilled Syringes
7.7.5.9 Autoinjector
7.7.5.10 Pen Injectors
7.7.5.11 Disposable
7.7.5.12 and others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Subcutaneous Drug Delivery Scope:
|
Report Data
|
Subcutaneous Drug Delivery Market
|
|
Subcutaneous Drug Delivery Market Size in 2025
|
USD XX million
|
|
Subcutaneous Drug Delivery CAGR 2025 - 2032
|
XX%
|
|
Subcutaneous Drug Delivery Base Year
|
2024
|
|
Subcutaneous Drug Delivery Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Becton Dickinson and Company., Novo Nordisk A/S, Johnson & Johnson, Novartis International AG, Amgen Inc., Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche AG., Consort Medical plc LaVision Biotec GmbH, Eli Lilly and Company., Merck & Co., Inc, Insulet Corporation., West Pharmaceutical Services, Inc. Gerresheimer AG..
|
|
Key Segments
|
By Type
Disposable
and Reusable
By Applications
Auto-immune Disorders
Neurological Disorders
Oncology Disorders
Hormonal Disorders
Allergy & Infectious Disorders
Ophthalmic Disorders
and Others
By Delivery System(Prefilled Syringes
Autoinjector
Pen Injectors
Disposable
and others
|
